From the Emory University School of Medicine (A.M., L.Z., Y.A., A.Q., V.V.), Atlanta, Georgia; Morehouse School of Medicine (N.S., G.G., R.D.-D.), Atlanta, Georgia; Centers for Disease Control and Prevention (C.D.S, W.C.H.), Atlanta, Georgia; and Emory Rollins School of Public Health (L.Z., V.V.), Atlanta, Georgia.
Address correspondence and reprint requests to Alanna Amyre Morris, MD,1364 Clifton Rd Suite D403B, Atlanta, GA 30322. E-mail: [email protected]
This work was supported by the funding from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute 1 U01 HL079156-01 (A.Q.) and 1 U01 HL79214-01 (G.G.); NIH, National Center for Research Resources (NCRR) Grant M01-RR00039 for the Emory General Clinical Research Center and NIH/NCRR 5P20RR11104 for the Morehouse Clinical Research Center; NIH K24HL077506-06 (V.V.); and NIH/NCRR 5U54RR022814 (R.D.-D.).
The authors have no financial conflicts of interest to disclose.
Received for publication September 12, 2010; revision received March 4, 2011.